Navigation Links
A New Treatment Discovered For Acute Lymphoblastic Leukemia

A study undertaken by a group of Spanish scientists, amongst which were members of the University Clinic of the University of Navarra and the Centre for Applied Medical Research// (CIMA) of the same university has recently discovered a new line of treatment for patients with acute lymphoblastic leukemia.

The conclusions of the research have been published in the official journal, Blood, of the American Haematology Association.

It should be noted that acute lymphoblastic leukemia is the most common oncological disease amongst children. This is why the application of this discovery could be highly beneficial for a special group of patients with this disorder – those who show the cellular control pathway known as WNT as altered, - and whose prognosis of this tumour disease is serious.

The WNT pathway is the device that a normal cell needs to activate in order to initiate a process of cell growth and which, once realized, should deactivate itself.

However, it has been shown that, in those groups of acute lymphoblastic leukemia patients with the worst prognoses, this cell control pathway appears to be constantly activated. This phenomenon occurs because the mechanisms controlling this pathway have been silenced due to a process that affects gene transcription and known as metilation. The WNT pathway activated in an ongoing manner gives rise to the expression of specific genes whose function is to activate the growth of tumour cells.

Administration of New Medicinal Drugs
The study has shown, with in vitro trials, that administering a type of medication which impedes this process of metilation or which inactivates the WNT pathway, results in the normalisation of this cell control pathway and, so, impedes the development of tumour cells, inducing the death of the leukemia cells.

In this way, this group of medicines will help to enhance chemotherapy results and raise the rates of survival amongst the
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Treatment Discovered For Acute Lymphoblastic Leukemia

(Date:7/11/2014)... (PRWEB) July 11, 2014 Volunteers from ... against drug abuse this week with drug education lectures, ... education booklet distribution in cities around the world. , ... U.S. National Institute on Drug Abuse, abuse of alcohol ... annually in crime, lost work, decreased productivity and healthcare. ...
(Date:7/11/2014)... Well Intervention Market report defines and segments the well intervention ... well intervention services market in Europe is estimated to grow ... 2018, at a CAGR of 7% from 2013 to 2018. ... Market report, to get an idea of the in-depth analysis ... the Europe well intervention market, and is supported by various ...
(Date:7/11/2014)... July 11, 2014 (HealthDay News) -- In people with ... are similar to that seen in drug addicts as ... are clear differences in brain activity between patients who ... mirror those of drug addicts," study author Dr. Valerie ... in a university news release. Voon,s research involved ...
(Date:7/11/2014)... 2014 The report “Probiotics Market ... Animal Feed), Applications (Regular, Therapeutic, Preventive Health Care) ... & Forecasts to 2019 ” defines and segments ... forecasting of the market value of probiotic products ... and restraining factors for the global market with ...
(Date:7/11/2014)... are widely applied in turf and ornamentals. They enhance ... turf and ornamentals in absorption of water, nutrient uptake, ... appear healthy and strong as a result of using ... few years. The most dominating region in biostimulants markets ... share in 2013, and is estimated to grow at ...
Breaking Medicine News(10 mins):Health News:Scientologists Taking Action against Drug Abuse 2Health News:Scientologists Taking Action against Drug Abuse 3Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Brains of Sex Addicts May Be Wired Like Those of Drug Addicts, Study Finds 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3
... , PHILADELPHIA, Dec. 2 Independence ... with Lincoln Financial Group. IBC will be the primary provider ... retirees, and their dependents across the nation. The Lincoln plan ... plans. , "I know I speak for all of us ...
... who have a prostate-specific antigen (PSA) value of less ... external beam radiation therapy (EBRT) are less likely to ... a study in the December 1 issue of the ... the American Society for Radiation Oncology (ASTRO). PSA levels ...
... ... microwave signal transmissions away from users will be available in early 2010 from Aerius ... ... transmissions away from users will be available in early 2010 from Aerius International Ltd. ...
... , ATLANTA, Dec. 2 In response ... FamilyLife, a non-profit ministry dedicated to supporting marriages and families, ... at a significant discount to military couples in Atlanta from ... Buckhead (3300 Peachtree Road NE). Weekend to Remember ...
... /PRNewswire/ -- The Universities of Sassari and Cagliari ... from the United States, announced today the results of a ... amounts of CLA (Conjugated Linoleic Acid), an Omega-6 polyunsaturated fatty ... bioactive properties for humans. , The study, conducted ...
... when women at high-risk of breast cancer are well-informed about ... prevention, only 6 percent said they were likely to take ... Center created a decision aid designed to inform women about ... was first used to stop breast cancer from returning and ...
Cached Medicine News:Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 3Health News:High-risk women reluctant to take tamoxifen to prevent breast cancer, U-M study finds 2
(Date:7/11/2014)... July 11, 2014 On ... down 0.52%, the Dow Jones Industrial Average finished the day ... 1,964.68, down 0.41%. The losses were broad based as eight ... S&P 500 Health Care Sector Index ended the day at ... the last one month. Investor-Edge has initiated coverage on the ...
(Date:7/11/2014)... , July 11, 2014 ... to Safety & Health Expo 2014 were ... move to London , ... attending exhibition.          ... http://photos.prnewswire.com/prnh/20140711/696892-a )      (Photo: ...
(Date:7/10/2014)... U.S. Department of Health and Human Services (HHS) has ... Medical Center Seidman Cancer Center totaling $4.7 million to ... for patients with complex cancer. Titled ... model developed at UH to enhance care for adult ... need for high health care utilization.  ...
Breaking Medicine Technology:Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4
... Pharmaceuticals, Inc. (Nasdaq: ALSE ), announced today that ... Altropane Parkinson,s or Essential Tremor (POET-2) Phase III ... the program was to acquire the set of Altropane images ... Phase III registration portion of the program. The Altropane ...
... Care approach designed to help improve medication adherence to ... 3 /PRNewswire/ -- A study ... ) found that nearly half of patients hospitalized for ... therapies, significantly increasing their risk for subsequent hospitalization within ...
Cached Medicine Technology:Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program 2Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program 3Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program 4Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program 5CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 2CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 3CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: